Note 10: Operating income The following table summarizes the operating income during the three and the nine months ended September 30, 2025 and 2024: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2025 | | 2024 | | 2025 | | 2024 | | Research tax credit | 2,774 | | | 1,072 | | | 4,991 | | | 3,640 | | | | | | | | | | | | | | | | | | | Total | 2,774 | | | 1,072 | | | 4,991 | | | 3,640 | |
The increase in Research tax credit during the three and the nine months ended September 30, 2025, is primarily due to the fact that more eligible activities have been carried out in the period, including the related costs of the FAREVA platform.
|